z-logo
open-access-imgOpen Access
Front & Back Matter
Publication year - 2017
Publication title -
neurodegenerative diseases
Language(s) - English
Resource type - Journals
eISSN - 1660-2862
pISSN - 1660-2854
DOI - 10.1159/000486290
Subject(s) - front (military) , neuroscience , medicine , physics , psychology , meteorology
Each paper needs an abstract of about 200 words, and should be structured as follows: Background: What prompted the study? Objective: What is the purpose of the study? Methods: How was the study carried out? Results: What are the most important findings? Conclusion: What is the most important conclusion? The abstract should not exceed 250 words, and any abbreviations must be explained. Footnotes: Avoid footnotes. When essential, they should be numbered consecutively and typed at the foot of the appropriate page. Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate sheets. Tables require a heading and figure legends should be supplied on a separate sheet. For the reproduction of illustrations, only good drawings and original photographs will be accepted; negatives or photocopies cannot be used. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 223 mm) or provide crop marks. Electronically submitted b/w halftone and color illustrations must have a final resolution of 300 dpi after scaling, and line drawings one of 800– 1,200 dpi. Color illustrations Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends. Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page. References: Identify references in the text with Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as [unpublished data] and not be included in the reference list. The list of references should include only those publications cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by their initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Examples (a) Papers published in periodicals: Desai MY, De la Peña-Almaguer E, Mannting F: Abnormal heart rate recovery after exercise: A comparison with known indicators of increased mortality. Cardiology 2001;96: 38–44. (b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858. (c) Books: Matheis G, Moritz A, Scholz M (eds): Leukocyte Depletion in Cardiac Surgery and Cardiology. Basel, Karger, 2002. (d) Edited books: Gladish GW, Haponik EF: Virtual Bronchoscopy; in Bolliger CT, Mathur PM (eds): Interventional Bronchoscopy. Prog Respir Res. Basel, Karger, 2000, vol 30, pp 253–266. Papers that have been submitted but are not yet accepted should not be listed in the bibliography, but can be referred to in the text as unpublished observations. If details of methods are only available in papers that are ‘in press’, copies of the papers should be included with the manuscript submitted to Neurodegenerative

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom